News

Brentuximab vedotin sBLA receives priority review
The US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for brentuximab...
The US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for brentuximab...
The US Food and Drug Administration (FDA) has lifted the clinical hold placed on a phase 1/2 trial of SEL24, a dual PIM/FLT3 kinase inhibitor, in...
A 72-year-old man has experienced fatigue, lethargy, and shortness of breath for three weeks. Is he just "slowing down," or is there another...
Recent study shows that a simple bedside pulse oximetry has helped reduce infant deaths from critical congenital heart disease by > 33%...
Researchers warn physicians to closely monitor new users of LABAs or LAMAs for cardiovascular symptoms.
WASHINGTON, DC—Age of seizure onset is significantly associated with age of menarche, according to research presented at the 71st Annual Meeting...
WASHINGTON, DC—Among patients with Dravet syndrome, adjunctive treatment with fenfluramine hydrochloride oral solution significantly reduces...
PARIS—Ibudilast decreases the rate of brain atrophy, compared with placebo, in patients with progressive multiple sclerosis (MS), according to top...
When a patient has a heart attack or stroke, it is critical for his or her clinician to perform a follow-up cholesterol test, according to a study...
Last year, the English county of Hertfordshire banned elective surgeries in smokers and obese patients until they stopped smoking or lost weight...